Luye Pharma Group Ltd. (2186.HK)
HKD 2.17
(-2.25%)
HKD 2.17
(-2.25%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 11.96 Billion CNY | -9.43% |
| 2022 | 13.2 Billion CNY | -1.93% |
| 2021 | 13.46 Billion CNY | 7.47% |
| 2020 | 12.53 Billion CNY | 26.05% |
| 2019 | 9.94 Billion CNY | 3.51% |
| 2018 | 9.6 Billion CNY | 148.54% |
| 2017 | 3.86 Billion CNY | 46.17% |
| 2016 | 2.64 Billion CNY | 110.94% |
| 2015 | 1.25 Billion CNY | 14.65% |
| 2014 | 1.09 Billion CNY | -26.62% |
| 2013 | 1.48 Billion CNY | 36.2% |
| 2012 | 1.09 Billion CNY | 4.17% |
| 2011 | 1.05 Billion CNY | 82.93% |
| 2010 | 573.98 Million CNY | 33.72% |
| 2009 | 429.24 Million CNY | 75.3% |
| 2008 | 244.85 Million CNY | -31.37% |
| 2007 | 356.76 Million CNY | 221.21% |
| 2006 | 111.06 Million CNY | 155.4% |
| 2005 | 43.48 Million CNY | -51.5% |
| 2004 | 89.66 Million CNY | -47.37% |
| 2003 | 170.37 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 13.11 Billion CNY | 9.63% |
| 2024 Q2 | 13.11 Billion CNY | 0.0% |
| 2023 Q3 | 11.96 Billion CNY | -15.2% |
| 2023 Q2 | 14.1 Billion CNY | 0.0% |
| 2023 Q1 | 14.1 Billion CNY | 6.8% |
| 2023 FY | 11.96 Billion CNY | -9.43% |
| 2023 Q4 | 11.96 Billion CNY | 0.0% |
| 2022 Q3 | 13.2 Billion CNY | 0.68% |
| 2022 Q2 | 13.11 Billion CNY | 0.0% |
| 2022 Q1 | 13.11 Billion CNY | -2.59% |
| 2022 FY | 13.2 Billion CNY | -1.93% |
| 2022 Q4 | 13.2 Billion CNY | 0.0% |
| 2021 Q3 | 13.46 Billion CNY | 10.88% |
| 2021 Q4 | 13.46 Billion CNY | 0.0% |
| 2021 Q1 | 12.14 Billion CNY | -3.07% |
| 2021 Q2 | 12.14 Billion CNY | 0.0% |
| 2021 FY | 13.46 Billion CNY | 7.47% |
| 2020 Q4 | 12.53 Billion CNY | 0.0% |
| 2020 Q1 | 11.74 Billion CNY | 18.11% |
| 2020 FY | 12.53 Billion CNY | 26.05% |
| 2020 Q3 | 12.53 Billion CNY | 6.72% |
| 2020 Q2 | 11.74 Billion CNY | 0.0% |
| 2019 Q3 | 10.48 Billion CNY | 4.12% |
| 2019 FY | 9.94 Billion CNY | 3.51% |
| 2019 Q1 | 10.07 Billion CNY | 4.86% |
| 2019 Q2 | 10.07 Billion CNY | 0.0% |
| 2019 Q4 | 9.94 Billion CNY | -5.2% |
| 2018 Q2 | 8.82 Billion CNY | 0.0% |
| 2018 Q1 | 8.82 Billion CNY | 128.48% |
| 2018 Q3 | 9.6 Billion CNY | 8.78% |
| 2018 Q4 | 9.6 Billion CNY | 0.0% |
| 2018 FY | 9.6 Billion CNY | 148.54% |
| 2017 Q2 | 4.25 Billion CNY | 0.0% |
| 2017 FY | 3.86 Billion CNY | 46.17% |
| 2017 Q4 | 3.86 Billion CNY | 0.0% |
| 2017 Q3 | 3.86 Billion CNY | -9.19% |
| 2017 Q1 | 4.25 Billion CNY | 60.97% |
| 2016 Q2 | 3.03 Billion CNY | 0.0% |
| 2016 Q3 | 2.64 Billion CNY | -12.96% |
| 2016 Q4 | 2.64 Billion CNY | 0.0% |
| 2016 FY | 2.64 Billion CNY | 110.94% |
| 2016 Q1 | 3.03 Billion CNY | 142.33% |
| 2015 Q4 | 1.25 Billion CNY | 0.0% |
| 2015 Q3 | 1.25 Billion CNY | -17.52% |
| 2015 Q2 | 1.51 Billion CNY | 0.0% |
| 2015 Q1 | 1.51 Billion CNY | 39.01% |
| 2015 FY | 1.25 Billion CNY | 14.65% |
| 2014 FY | 1.09 Billion CNY | -26.62% |
| 2014 Q2 | 1.8 Billion CNY | 0.0% |
| 2014 Q1 | 1.8 Billion CNY | 21.42% |
| 2014 Q3 | 1.09 Billion CNY | -39.56% |
| 2014 Q4 | 1.09 Billion CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 FY | 1.48 Billion CNY | 36.2% |
| 2013 Q4 | 1.48 Billion CNY | 0.0% |
| 2013 Q3 | 1.48 Billion CNY | 0.0% |
| 2012 Q1 | 1.13 Billion CNY | 8.38% |
| 2012 Q2 | 1.17 Billion CNY | 3.24% |
| 2012 FY | 1.09 Billion CNY | 4.17% |
| 2011 Q2 | 727.16 Million CNY | 19.23% |
| 2011 FY | 1.05 Billion CNY | 82.93% |
| 2011 Q3 | 987.89 Million CNY | 35.86% |
| 2011 Q4 | 1.05 Billion CNY | 6.29% |
| 2011 Q1 | 609.86 Million CNY | 6.25% |
| 2010 Q1 | 489.1 Million CNY | 13.95% |
| 2010 FY | 573.98 Million CNY | 33.72% |
| 2010 Q4 | 573.98 Million CNY | 6.05% |
| 2010 Q3 | 541.24 Million CNY | 4.85% |
| 2010 Q2 | 516.22 Million CNY | 5.54% |
| 2009 FY | 429.24 Million CNY | 75.3% |
| 2009 Q4 | 429.24 Million CNY | 0.0% |
| 2008 FY | 244.85 Million CNY | -31.37% |
| 2007 FY | 356.76 Million CNY | 221.21% |
| 2006 FY | 111.06 Million CNY | 155.4% |
| 2005 FY | 43.48 Million CNY | -51.5% |
| 2004 FY | 89.66 Million CNY | -47.37% |
| 2003 FY | 170.37 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 12.02 Billion HKD | 0.538% |